Tech Company Financing Transactions
Regenesis Biomedical Funding Round
On 6/6/2011, Regenesis Biomedical secured $5.3 million in Series C financing from Fulcrum Equity Partners, TGAP Ventures and Solstice Capital.
Transaction Overview
Fulcrum Equity Partners (Lead Investor) (Thomas Greer)
TGAP Ventures (Lead Investor) (Jack Ahrens)
Solstice Capital (Harry George)
Company Information
Scottsdale, AZ 85250
USA
Management Team
Browse more venture capital transactions:
Prev: 6/6/2011: Infineta Systems venture capital transaction
Next: 6/6/2011: Aquantia venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs